Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery - Scorecard - MDSpire
Advertisement
Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery
Clinical Scorecard: Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients with primary open-angle glaucoma, pseudoexfoliation glaucoma, or pigment dispersion glaucoma undergoing Preserflo MicroShunt implantation.
Care Setting
Key Highlights
BWT and TBH measurements showed no significant correlation with secondary interventions post-PM surgery.
10 out of 23 patients required secondary interventions within 48 weeks after PM implantation.
AS-OCTA-derived bleb vessel density (BVD) may be a better predictor for secondary interventions than BWT/TBH.
Larger studies are necessary to confirm these hypothesis-generating findings.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with primary open-angle glaucoma, pseudoexfoliation glaucoma, or pigment dispersion glaucoma.
PM implantation is increasingly used as a first-line surgical option for IOP reduction.
Clinical Best Practices
Utilize AS-OCT for objective assessment of bleb parameters.
Implement an intensified follow-up regime for patients post-PM surgery, including a timeline for assessments.
by Martin Kallab, Sarah Hinterberger, Sophie Schneider, Olivia Murauer, Anna-Sophie Reisinger, Susanne Strohmaier, Alex S. Huang, Matthias Bolz, Clemens A. Strohmaier
